DELCATH SYSTEMS, INC. (DCTH) research
DELCATH SYSTEMS, INC.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $16.40
- As of
DELCATH SYSTEMS, INC. (DCTH): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-14.
As of . Source: SEC EDGAR filings for DCTH. Method and limitations.
Share the DCTH intelligence card
See DCTH live in the terminal
Track DCTH's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live DCTH terminal, freeActive signals for DCTH
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 86% of DCTH (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 87% of DCTH (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 76% of DCTH (2026Q2)
- mediumNEW_POSITION
D. E. Shaw & Co., Inc. new position in DCTH
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 86% of DCTH (2026Q2)
FREE, NO ACCOUNT
Every signal on DCTH, as it fires
You are seeing 5 of 19 signals recorded on DCTH since 2026-05-29.
The five above all landed on 2026-09-06. The other 14 were recorded on 4 other days. 15 of the 19 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in DCTH (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 24661P807 · 2026Q2 | $7.1M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 24661P807 · 2026Q2 | $729K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 24661P807 · 2026Q2 | $189K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 24661P807 · 2026Q2 | $127K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, DCTH
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
DCTH against its peers
DCTH's operating margin of 0.8% ranks in the 84th percentile of 21 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2025-12-31.
| Metric | DCTH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 85.2M USD | 100M USD | 34 | 21 |
| Gross margin | 86.2% | 65.1% | 93 | 20 |
| Operating margin | 0.8% | -33.7% | 84 | 21 |
| Net margin | 3.2% | -28.5% | 80 | 21 |
| Return on equity | 2.4% | -28.6% | 79 | 20 |
| P / E | 234.3x | n/a | n/a | 2 |
Peers (22): KIDS, SENS, TCMD, NPCE, SSII, MASS, QDEL, CLPT, SIBN, INMD, CV, RCEL, OFIX, VMD, CBLL, CATX, TLSI, LAB, ENOV, TMCI, BBNX, AVNS. Left out: BWAY (period gap), MOBI (no annual filing), LMRI (no annual filing). Fiscal periods ending between 2025-12-28 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (DCTH: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more DCTH signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to DCTHand get the insider, 13F, options, and confluence read in one view.